ALTERITY THERAPEUTICS LIMITED SPON ADS EACH REP 600 ORD SHS (POST SPT)
(NASDAQ: ATHE)

Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.

2.070

+0.050 (+2.48%)
价格区间 - - -   (-%)
开盘 2.020
昨收 2.020
2.650
买盘 8
2.850
卖盘 8
成交量 68,744
成交额 -
注释
数据延迟。最后一次更新29 Mar 2024 04:00.
数据提供商
查看所有活动


杰出贡献者

USNews avatar
343
追随者 273
帖子 1283231

Loading Chart...

Please login to view stock data and analysis